Elon Musk Reveals What Happened After His 2nd COVID Booster Shot

By
David Rufful
-
OPINION | This article contains commentary that reflects the author's opinion.

Elon Musk shared his experience following his second COVID booster shot and explained that he experienced “major side effects.”

In several tweets, Musk said that he felt like he “was dying.” He also said that a cousin of his was in “peak health” and suffered from myocarditis.

🚨 POLL: Will you get a 2nd booster?
YES 👍 or NO 👎

Myocarditis is an inflammation of the heart, which is listed as a possible side effect of some coronavirus vaccines.

Musk tweeted, “I had major side effects from my second booster shot. Felt like I was dying for several days.”

“Hopefully, no permanent damage, but I dunno.”

He continued, “And my cousin, who is young & in peak health, had a serious case of myocarditis. He had to go to the hospital.”

Musk said the second booster was a requirement to visit a Tesla location in Berlin, Germany. “Was required to visit Tesla Giga Berlin. Not my choice,” he said.

Many Americans have been suspicious of the coercing and outright bribing of individuals to inject the new COVID-19 vaccines and booster shots.

It’s widely known that the Johnson & Johnson coronavirus vaccine has caused at least 60 cases of life-threatening blood clots and nine confirmed deaths, according to Yale Medicine, although the data is likely incomplete. More than 18 million people received the J&J shot.

In a new development, the Centers for Disease Control and Prevention (CDC) announced a “safety signal” regarding the COVID-19 vaccine from Pfizer (Bivalent Pfizer-BioNTech). For certain people who are 65 and older, there is a possible safety concern that the vaccine “creates an increased risk of ischemic stroke,” according to Fox News.

Ischemic stroke occurs when blood clots or other particles block the blood vessels to the brain.

This “safety signal” says there’s a possible increase of stroke for people 65 and older, but the CDC is still conducting further investigation into the vaccine from Bivalent Pfizer-BioNTech.

The signal hasn’t been identified with the Bivalent Moderna COVID-19 vaccine.

“Following the availability and use of the updated (bivalent) COVID-19 vaccines, CDC’s Vaccine Safety Datalink (VSD), a near real-time surveillance system, met the statistical criteria to prompt additional investigation into whether there was a safety concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent,” the CDC said.

“Rapid-response investigation of the signal in the VSD raised a question of whether people 65 and older who have received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent were more likely to have an ischemic stroke in the 21 days following vaccination compared with days 22-44 following vaccination.”

CNN reported on the news of the safety signal, but emphasized that the CDC still recommends nearly everyone receives the vaccine and boosters.

More from Fox News:

In the statement, the CDC pointed out that a large study of updated bivalent vaccines from Pfizer-BioNTech “using the Centers for Medicare and Medicaid Services database revealed no increased risk of ischemic stroke.”

The agency also said that the Vaccine Adverse Event Reporting System (VAERS) managed by CDC and FDA has not seen an increase in reporting of ischemic strokes following the updated (bivalent) vaccine.

In a statement to Fox News Digital, a spokesperson for Pfizer said, “Pfizer and BioNTech have been made aware of limited reports of ischemic stroke that have been observed in the CDC Vaccine Safety DataLink (VSD) database in people 65 and older following vaccination with the Omicron BA.4/BA.5-adapted bivalent COVID-19 Vaccine by Pfizer and BioNTech.”

“Neither Pfizer and BioNTech nor the CDC or the U.S. Food and Drug Administration (FDA) have observed similar findings across numerous other monitoring systems in the U.S. and globally and there is no evidence to conclude that ischemic stroke is associated with the use of the companies’ COVID-19 vaccines,” the spokesperson continued.

“Compared to published incidence rates of ischemic stroke in this older population, the companies to date have observed a lower number of reported ischemic strokes following the vaccination with the Omicron BA.4/BA.5-adapted bivalent vaccine. The CDC continues to recommend vaccination with the Pfizer-BioNTech Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for all authorized ages and indications.”